BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CLH
Clean Harbors, Inc.
CLH has the edge over BA overall, supported by lower modeled downside and stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CLH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
CLH's revenue, profitability, cash flow and balance sheet are all currently healthy.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CLH in the historical PE scenario, which offers more potential upside but is not a forecast.
CLH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $217 | -26% |
| Current | 30x | $294 | — |
| Forward | 30x | $294 | — |
| Fair | 31x | $307 | +4.3% |
| Expensive | 37x | $366 | +24% |
Historical ranges are pointers, not guarantees.
CLH's PE is in its fair range at 29.5x. On analysts' estimates for next year's earnings, today's price would be 30.2x.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CLH on the outlook, with more favorable profitability expectations.
CLH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CLH, but weaker profitability. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CLH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.74 | -2.3% |
| Q3 2026 | $9.96 | +38% |
| Q2 2026 | $8.24 | +16% |
| Q1 2026 | $7.38 | +2.2% |
| Q4 2025 | $7.28 | -1.9% |
| Q3 2025 | $7.21 | -6.1% |
| Q2 2025 | $7.12 | -1.7% |
| Q1 2025 | $7.22 | +4.5% |
| Q4 2024 | $7.42 | +6.8% |
CLH has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CLH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CLH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +21% |
| Q2 2026 | $1.7B | +12% |
| Q1 2026 | $1.5B | +1.9% |
| Q4 2025 | $1.5B | +4.8% |
| Q3 2025 | $1.5B | +1.3% |
| Q2 2025 | $1.5B | -0.2% |
| Q1 2025 | $1.4B | +4% |
| Q4 2024 | $1.4B | +6.9% |
CLH's revenue has grown year over year for five quarters in a row: $1.9B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +4.6 points |
| Q2 2026 | 16% | +1.9 points |
| Q1 2026 | 8.2% | +0.4 points |
| Q4 2025 | 11% | +1 points |
| Q3 2025 | 12% | -0.1 points |
| Q2 2025 | 14% | -0.3 points |
| Q1 2025 | 7.8% | -1.3 points |
| Q4 2024 | 9.6% | -1.4 points |
CLH has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CLH on cash flow, with more consistent year-over-year improvement.
CLH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $246.4M | +19% |
| Q2 2026 | $113M | -4.3% |
| Q1 2026 | -$92.1M | +$24.9M |
| Q4 2025 | $233.3M | -3.4% |
| Q3 2025 | $207.5M | +46% |
| Q2 2025 | $118M | +46% |
| Q1 2025 | -$117.1M | +$2.3M |
| Q4 2024 | $241.5M | +43% |
CLH generated $501M in free cash flow over the past year, up 11% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CLH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -64K shares |
| 1 year | -1.5% | -816K shares |
| 3 years | -2.8% | -1.5M shares |
| 5 years | -3.3% | -1.8M shares |
| Available history | -5.8% | -3.2M shares |
CLH has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $27.1M |
| Q1 2026 | $25M |
| Q4 2025 | $133M |
| Q3 2025 | $50M |
| Q2 2025 | $12M |
| Q1 2025 | $55M |
| Q4 2024 | $25M |
CLH spent $210M buying back its own shares over the past year, up 48% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CLH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.8x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 2.0x | Healthy |
CLH has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CLH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.6 | Neutral |
| Stochastic | 18.5 | Oversold |
CLH's weekly RSI is 46 (neutral) and its Stochastic is 19 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CLH on valuation relative to its sector.
CLH PE vs Industrials Sector
| Metric | CLH | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 24x | 23% above |
| PE % | 41 | 58 | 17 pts below |
CLH is trading at 30x earnings, a 23% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CLH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $308.4 | 4.7% below |
| 20 week MA | $310.1 | 5.2% below |
| 50 week MA | $290.6 | 1.1% above |
| 100 week MA | $257.9 | 14% above |
| 200 week MA | $222.0 | 32% above |
CLH has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CLH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $86.2 | $75.3 | -13% |
| 2021 | $75.3 | $95.6 | +27% |
| 2022 | $95.6 | $114.8 | +20% |
| 2023 | $114.8 | $174.5 | +52% |
| 2024 | $174.5 | $229.6 | +32% |
| 2025 | $229.6 | $240.8 | +4.9% |
| 2026 YTD | $240.8 | $293.8 | +22% |
CLH has the edge over BA on returns for 2026, with the stronger performance.